Salix Among National HBPA Convention Discussion Topics
Tom LaMarra
January 11, 2012
Furosemide, known as Salix, will be discussed Jan. 14 during the National HBPA Medication Committee forum.
Furosemide, known as Salix, will be discussed Jan. 14 during the National HBPA Medication Committee forum.
A percentage of revenue from video lottery terminals and purse accounts could go to help retired racehorses.
The AAEP is developing protocol to improve the relationship among owners, trainers, and veterinarians.
The racing industry is making significant progress in identifying causes for equine injuries, two vets agree.
There is a decided split between trainers and breeders on the issue of race day furosemide in Thoroughbreds.
The meeting began with several presentations on furosemide and EIPH, the condition the medication treats.
The National Thoroughbred Racing Association Safety and Integrity Alliance considers the presence of a ‘safety
A New York lawmaker will introduce legislation banning “performance-enhancing drugs” in racing, such as Salix.
Officials: Report that shows 99.5% of samples tested “clean” in 2010 dispels claims that racing is drug-ridden
The combination of genomics and pedigree theory hasn’t come close to reaching its potential, speakers agreed.
The first day of the Thoroughbred Genetics, Pedigree, and Performance Conference provided informative sessions
Thoroughbred horsemen’s groups are drawing a line in the sand when it comes to the anti-bleeding drug Salix.
The Jockey Club reiterated its calls for a ban of Salix but made it clear it wants medication-free racing.
The AGSC will employ a program banning race-day medications in graded 2-year-old Thoroughbred stakes races.
The RMTC will continue to study a pilot program proposal to ban the use of Salix in 2-year-old Thoroughbreds.
For the most part Thoroughbred racing industry organizations that have weighed in on the plan by Breeders’ Cup
Stay on top of the most recent Horse Health news with
